Odyssey Therapeutics Appoints Timothy P. Walbert and Ian F. Smith to Board of Directors
Key Highlights Timothy P. Walbert: Former Chairman, President & CEO of Horizon Therapeutics, instrumental in $28.3 billion acquisition…
Browsing Tag
Odyssey Therapeutics
2 posts
Odyssey Therapeutics Appoints William Roush, Ph.D., as EVP and Head of Small Molecule Research
Key Highlights Dr. William Roush appointed EVP and head of small molecule research. Focus on advancing small molecule…